Trials / Recruiting
RecruitingNCT04704271
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Detailed description
To characterize the acute effects of vaporized THC in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled THC | 4 mg inhaled THC |
| DRUG | Placebo | Inhaled placebo (no active cannabinoids) |
Timeline
- Start date
- 2019-10-09
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2021-01-11
- Last updated
- 2025-03-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04704271. Inclusion in this directory is not an endorsement.